⚕ GalenOps CRO console
← 716 (USA)

716-1418

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 716 (USA) (Dr. Ito) · consented 2013-05-05
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-05 (study day 1.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07; relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-07; relationship: POSSIBLE

mild assessed 2026-08-18

Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-26 (study day 145.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-09-26 (study day 145.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-07 (study day 3.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-05 (study day 1.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild URTICARIA — outcome: RECOVERED/RESOLVED; onset 2013-05-05 (study day 1.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate VISION BLURRED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07; relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate VISION BLURRED — outcome: RECOVERED/RESOLVED; onset 2013-07; relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.